---
title: "Sinopharm Accord (000028.SZ) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000028.SZ/norm.md"
symbol: "000028.SZ"
name: "Sinopharm Accord"
parent: "https://longbridge.com/en/quote/000028.SZ.md"
datetime: "2026-03-10T01:28:58.350Z"
locales:
  - [en](https://longbridge.com/en/quote/000028.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000028.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000028.SZ/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/000028.SZ/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/000028.SZ/norm.md)


# Sinopharm Accord (000028.SZ) — Financial Reports

## Income Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.5200 | 0.6100 | 0.5900 | -0.7699 | 0.5711 |
| ROE | 6.37% | 7.48% | 7.36% | -9.46% | 7.18% |
| Revenue | 18.33B | 18.50B | 18.29B | 17.91B | 18.68B |
| Net income | 291.21M | 337.91M | 328.00M | -423.05M | 322.05M |
| Operating income | 440.75M | 445.21M | 393.15M | 240.81M | 410.48M |
| Gross margin | 10.18% | 10.92% | 10.34% | 11.49% | 10.79% |
| Net margin | 1.59% | 1.83% | 1.79% | -2.36% | 1.72% |
| Profit quality | -92.18% | 24.30% | -21.63% | 12.10% | 116.71% |

## Balance Sheet (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 50.56B | 50.43B | 50.02B | 47.56B | 51.98B |
| Leverage | 2.35 | 2.37 | 2.37 | 2.29 | 2.40 |
| BVPS | 33.11 | 32.59 | 32.34 | 31.75 | 32.52 |
| Turnover | 1.42 | 1.44 | 1.45 | 1.56 | 1.47 |
| Cash & STI | 5.65B | 6.80B | 5.54B | 7.41B | 5.43B |
| Inv & Rec | 8.34B | 8.06B | 8.02B | 7.41B | 8.39B |
| LT assets | 2.91B | 3.08B | 3.33B | 3.48B | 3.76B |
| Net debt | -257.54M | -29.12M | 428.73M | -1.67B | 1.47B |

## Cash Flow Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -478.14M | 1.83B | -1.82B | 1.99B | 351.71M |
| Investing CF | -13.01M | -4.13M | -59.94M | -79.45M | 98.18M |
| Financing CF | -651.01M | -754.90M | 92.06M | 154.99M | -939.44M |
| Free CF | -790.94M | 1.07B | -2.35B | 4.58B | -827.91M |
| OCF coverage | 493.34% | 129.71% | -471.15% | 112.20% | -123.74% |
| Repaid & issued | 477.07M | 381.57M | 637.47M | 573.62M | -132.22M |
| CapEx | -58.77M | -50.09M | -64.31M | -79.36M | -64.17M |

## Distribution Plan

**Dividend Yield**: 1.43

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.366CNY | 2025-06-24 | 2025-06-25 | 2025-06-25 |
| Cash Dividend: 
0.68CNY | 2024-06-24 | 2024-06-25 | 2024-06-25 |
| Cash Dividend: 
0.8CNY. 
Share conversation: 0.3 for 1 | 2023-05-31 | 2023-06-01 | 2023-06-01 |